U-Blot® Research Grade corveldebartCat. No. WA2632$9,999
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade corveldebartCat. No. WA2632
U-Blot® Research Grade Corifollitropin alfaCat. No. WA2631
U-Blot® Research Grade CoramitugCat. No. WA2630
U-Blot® Research Grade corabotaseCat. No. WA2629
U-Blot® Research Grade CoprelotamabCat. No. WA2628
U-Blot® Research Grade ConcizumabCat. No. WA2627
U-Blot® Research Grade ConberceptCat. No. WA2626
U-Blot® Research Grade ConatumumabCat. No. WA2625
U-Blot® Research Grade ComekibartCat. No. WA2624
U-Blot® Research Grade ColtuximabCat. No. WA2623
U-Blot® Research Grade CofetuzumabCat. No. WA2622
U-Blot® Research Grade CodrituzumabCat. No. WA2621